Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure. Academic Article uri icon

Overview

abstract

  • The use of phosphodiesterase inhibitors such as milrinone in the treatment of severe heart failure is frequently restricted because they cause vasodilation and hypotension. In patients with decompensated heart failure with hypotension after treatment with milrinone, low doses of vasopressin restored blood pressure without inhibiting the inotropic effect of milrinone.

publication date

  • February 15, 2000

Research

keywords

  • 3',5'-Cyclic-AMP Phosphodiesterases
  • Heart Failure
  • Hypotension
  • Milrinone
  • Phosphodiesterase Inhibitors
  • Vasoconstrictor Agents
  • Vasopressins

Identity

Scopus Document Identifier

  • 0033960832

PubMed ID

  • 10728962

Additional Document Info

volume

  • 85

issue

  • 4